Lv3
280 积分 2021-07-26 加入
Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia
11小时前
求助中
Discovery of Pyrrolopyrazine Carboxamide Derivatives as Potent and Selective FGFR2/3 Inhibitors that Overcome Mutant Resistance
1个月前
已完结
Biomarkers for Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced/Metastatic Breast Cancer: Translation to Clinical Practice
1个月前
已完结
Discovery of Novel PROTAC-Based HPK1 Degraders with High Potency and Selectivity for Cancer Immunotherapy
2个月前
已完结
Structure-Guided Optimization of 2-Aminoquinazoline Hematopoietic Progenitor Kinase 1 Inhibitors for Improved Oral Bioavailability and Synergistic Antitumor Immunity
2个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
3个月前
已完结
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations
3个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
3个月前
已完结
IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
4个月前
已完结
Can autoimmune diseases be cured? Scientists see hope at last
7个月前
已完结
皖公网安备34019202002308
